SCHEDULE: Nemean Asset Management, Oliveira Disclose 2.4% Forte Biosciences Stake

Nemean Asset Management, LLC and Steven Michael Oliveira have disclosed a 2.4% beneficial ownership stake in Forte Biosciences, Inc. common stock.

Summary

• Steven Michael Oliveira and Nemean Asset Management, LLC have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Forte Biosciences, Inc.
• They collectively beneficially own 300,100 shares of Forte Biosciences, Inc. Common Stock, $0.001 par value.
• This ownership represents 2.4% of the company's outstanding common stock.
• The reporting persons indicate shared voting power and shared dispositive power over the 300,100 shares.
• The filing certifies that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: This is a routine disclosure of beneficial ownership, which is a factual reporting requirement and does not inherently convey positive or negative sentiment regarding the company's operational performance or strategic direction.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The disclosure of a significant, albeit non-controlling, institutional investor could be viewed as a vote of confidence in Forte Biosciences, Inc. by Nemean Asset Management, LLC and Steven Michael Oliveira.

Key Dates

Keywords

Forte Biosciences, Nemean Asset Management, Steven Michael Oliveira, Schedule 13G, beneficial ownership, common stock, SEC filing, institutional ownership